You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interferon-Free

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, B-Cell Trial in Guangzhou (Rituximab Biosimilar, Pegylated Interferon a-2b)

Recruiting
  • Lymphoma, B-Cell
  • Rituximab Biosimilar
  • Pegylated Interferon α-2b
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Apr 6, 2022

Action of Interferon in Treatment of Myeloproliferative

Recruiting
  • Myeloproliferative Neoplasm
    • Villejuif, Ile De France, France
      Inserm U1287
    Apr 28, 2023

    Acute Leukemia, MDS Trial in Atlanta (Interferon gamma (IFN?)-primed human bone marrow-derived mesenchymal stromal cells)

    Recruiting
    • Acute Leukemia
    • Myelodysplastic Syndromes
    • Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
    • Atlanta, Georgia
    • +2 more
    Jul 15, 2022

    HIV Trial run by the NIAID (CD4-IgG, Zidovudine, Interferon alfa-n1)

    Completed
    • HIV Infections
    • Bethesda, Maryland
      Natl Inst of Allergy & Infect Dis / Cln Ctr
    Oct 26, 2021

    Melanoma (Skin) Trial in Worldwide (interferon alfa-2b, observation)

    Active, not recruiting
    Has Results
    • Melanoma (Skin)
    • interferon alfa-2b
    • observation
    • Birmingham, Alabama
    • +532 more
    Jun 8, 2022

    Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

    Active, not recruiting
    • Triple -Negative Breast Cancer
    • +4 more
    • Biopsy
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Aug 1, 2022

    Insulin Resistance Trial in Geneva (Ledipasvir 90 mg/Sofosbuvir 400 mg, Ribavirin)

    Completed
    • Insulin Resistance
    • Geneva, GE, Switzerland
      Division of Gastroenterology and hepatology, University Hospital
    Apr 29, 2019

    Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b

    Recruiting
    • Hepatocellular Carcinoma
    • Shanghai, China
      Zhongshan Hospital, Fudan University
    Mar 28, 2022

    Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

    Recruiting
    • Stage III Hepatocellular Carcinoma AJCC v8
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 18, 2021

    Locally Advanced or Metastatic Solid Tumors Trial in Beijing (MSC-IFNa, Nab paclitaxel, Cyclophosphamide)

    Recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • MSC-IFNα
    • +3 more
    • Beijing, China
      Department of Biotherapeutic, Chinese PLA General Hospital
    Jan 29, 2023

    Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)

    Completed
    • Advanced Renal Cell Carcinoma
    • Pazopanib + interferon alpha 2A
    • Hospitalet de Llobregat, Barcelona, Spain
    • +12 more
    Mar 9, 2022

    Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

    Recruiting
    • Polycythemia Vera
    • London, United Kingdom
    • +1 more
    Nov 29, 2021

    Stage IV NSCLC Trial in Czechia, Slovakia (DCVAC add on to SOC, DCVAC and immune enhancers add on to SOC, Standard of Care

    Completed
    • Stage IV Non-small Cell Lung Cancer
    • DCVAC add on to SOC
    • +2 more
    • Brno, Czechia
    • +17 more
    May 3, 2022

    Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

    Completed
    • Relapsing Multiple Sclerosis (RMS)
    • Rebif (Interferon beta-1a)
    • Alger, Algeria
    • +40 more
    Mar 22, 2022

    Long Term Follow up of Chronic HCV Patients Receiving DAAS

    Recruiting
    • Chronic Hepatitis c
      • Sohag, Egypt
        Sohag University Hospital
      Jun 29, 2022

      Sars-CoV2, Covid-19 Trial in Brazil, Canada (Peginterferon Lambda-1A, )

      Recruiting
      • Sars-CoV2
      • Covid-19
      • Peginterferon Lambda-1A
      • placebo
      • Botucatu, Brazil
      • +6 more
      Jan 17, 2022

      Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Treatment-free Remission
      • TFR(Treatment-Free Remission)
      • (no location specified)
      Jun 27, 2022

      IBD, Crohn Disease, Ulcerative Colitis Trial in Orléans (Blood and fecal samples, Coolonic biopsies)

      Recruiting
      • Inflammatory Bowel Diseases
      • +2 more
      • Blood and fecal samples
      • Coolonic biopsies
      • Orléans, France
        CHR Orléans
      Jun 14, 2023

      Against HCV Based on Direct-acting Antivirals in Real-life

      Completed
      • Chronic Hepatitis C Infection
      • Seville, Andalusia, Spain
        Valme University Hospital
      Jun 22, 2022

      Solid Tumor, Adult Trial (EOC202, albumin-bound paclitaxel)

      Not yet recruiting
      • Solid Tumor, Adult
      • EOC202
      • albumin-bound paclitaxel
      • (no location specified)
      Apr 7, 2022

      Gastric Cancer Trial in Taiwan (AST-301, rhuGM-CSF)

      Not yet recruiting
      • Gastric Cancer
      • Kaohsiung, Taiwan
      • +5 more
      Mar 14, 2023

      Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in Netherlands (Capecitabine, Oxaliplatin, Retifanlimab)

      Recruiting
      • Gastric Adenocarcinoma
      • Esophageal Adenocarcinoma
      • Amsterdam, Netherlands
      • +7 more
      Jan 31, 2022

      Healthy Subjects, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Interferon beta-1a, Peginterferon beta-1a, Placebo)

      Completed
      • Healthy Subjects
      • +2 more
      • Interferon beta-1a
      • +2 more
      • West Bend, Wisconsin
        Spaulding Clinical Research
      Aug 16, 2021

      Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)

      Active, not recruiting
      Has Results
      • Malignant Melanoma
      • Peginterferon alfa-2b
      • +2 more
      • San Diego, California
      • +2 more
      Apr 1, 2022

      Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)

      Recruiting
      • Solid Tumor
      • +9 more
      • MEM-288 Intratumoral Injection
      • Tampa, Florida
      • +1 more
      Jun 27, 2022